TVTX

Travere Therapeutics (TVTX)

About Travere Therapeutics (TVTX)

Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm's products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 7, 2008 and is headquartered in San Diego, CA.

Details

Daily high

$21.35

Daily low

$20.70

Price at open

$21.24

52 Week High

$25.29

52 Week Low

$5.12

Market cap

1.9B

Dividend yield

0.00%

Volume

975,544

Avg. volume

1.7M

P/E ratio

-5.19

Travere Therapeutics News